This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Boots has launched a private respiratory syncytial virus (RSV) vaccination service priced at £245. The chain claims it has become the ‘first multiple pharmacy’ to launch such a service. It comes as the UK Health Security Agency (UKHSA) warned RSV was circulating above baseline levels, with particularly pronounced increases in those under five years old. […] The post Boots launches private RSV vaccination service appeared first on The Pharmacist.
The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is participating in the 43rd India International Trade Fair (IITF) 2024. The exhibition highlights the milestones and initiatives under PMBJP, emphasising the mission to provide quality and affordable medicines across India.
Merck Life Science in India signed a Memorandum of Understanding (MoU) with GeNext Genomics, an emerging biotech company. This collaboration aims to combine local expertise with global biomanufacturing capabilities The MoU was signed between Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr Ashwin Kashikar, Managing Director, Genext Genomics; Supriya Kashikar, Founder & CEO, GeNext Genomics and Ravi Kashikar, Chairman and Founder of Ankur Seeds.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The pharmaceutical analytical testing market is seeing significant growth following a greater incidence in the complexity of medicine development and higher demand for biologics and biosimilars, according to a report by Straits Research Pvt. Ltd. Their analysis projected that the market will exceed a value of $15.46 billion by 2032. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.
The United States Food and Drug Administration inspected Alembic Pharmaceuticals’ Solid Oral Formulation Facility (F-4) at Jarod. The scheduled GMP inspection was conducted from November 14, 2024, to November 22, 2024. The USFDA issued a Form 483 with five procedural observations. The post Alembic Pharma gets form 483 with five procedural observations by USFDA appeared first on Express Pharma.
105
105
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The United States Food and Drug Administration inspected Alembic Pharmaceuticals’ Solid Oral Formulation Facility (F-4) at Jarod. The scheduled GMP inspection was conducted from November 14, 2024, to November 22, 2024. The USFDA issued a Form 483 with five procedural observations. The post Alembic Pharma gets form 483 with five procedural observations by USFDA appeared first on Express Pharma.
Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.
Biologic therapies are revolutionising severe asthma management by targeting specific inflammatory pathways, shifting care from symptom control to potential remission. Real-world evidence underscores their efficacy across diverse patient profiles, including those with complex asthma cases. However, barriers such as cost and accessibility persist, highlighting the urgent need for equitable healthcare solutions to ensure widespread adoption of these transformative treatments, according to GlobalDa
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
With the rapid development of antibiotics in the 1930s, phage therapy - using viruses known as bacteriophages or phages to tackle bacterial infections - fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists - although it remains complex in practice because of the great diversity and specificity of phages.
The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the stage for a pair of readouts with implications for weight loss research.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Watch this exclusive interview with health innovators Lori Fletcher and Amber Beimer from Advanced Clinical as they discuss the latest trends and advancements in the Functional Service Provider (FSP) field.
GP leaders in England have voted in favour of terminating pharmacy blood pressure checks with ‘immediate effect’. The British Medical Associations (BMA) Local Medical Committee (LMC) Conference saw GPs debate community pharmacy funding and place emphasis on the sector’s ‘core work’ of dispensing. The motion, proposed by Devon LMC, suggested that pharmacy blood pressure checks […] The post GP leaders vote to ‘terminate’ pharmacy blood pressure checks appeared first on The Pharmacist.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
In the second part of this roundtable discussion, key opinion leaders discuss the potential technological challenges surrounding RFID, and the likelihood of not only utilizing this tech at the item level but for product security purposes as well.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pathway is now the first and only FDA-approved companion diagnostic for identifying HER2-positive biliary tract cancer patients eligible for treatment with Ziihera.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
110 
Let's personalize your content